 Presentations showcase breadth of Vor Bios multiplex editing capability including base editing of human hematopoietic stem and progenitor cells HSPCs enabling new therapeutic approaches following transplant in patients with acute myeloid leukemia AML Presentations showcase breadth of Vor Bios multiplex editing capability including base editing of human hematopoietic stem and progenitor cells HSPCs enabling new therapeutic approaches following transplant in patients with acute myeloid leukemia AML 